Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis.
Hege F BergMarta Espevold HjelmelandHilde LienHeidi EspedalTina FonnesAashish SrivastavaTomasz StokowyElin StrandOlivera BozickovicIngunn M StefanssonLine BjørgeJone TrovikIngfrid S HaldorsenErling A HoivikCamilla KrakstadPublished in: Communications medicine (2021)
We establish robust model systems that capture both the diversity of endometrial tumors and intra-tumor heterogeneity. These models are highly relevant preclinical tools for the elucidation of the molecular pathogenesis of EC and identification of potential treatment strategies.